Study Reveals Positive Impact of Primary PCI on Elderly Chinese Patients with Heart Attacks
In a recent study conducted in China, researchers explored the prevalence and outcomes of primary percutaneous coronary intervention (PCI) in individuals aged 75 years and older who experienced ST-segment elevation myocardial infarction (STEMI). The research, based on data collected from a multicenter registry between 2013 and 2014, provides insights into the underutilization of primary PCI in Chinese clinical practice and emphasizes its significant potential to improve outcomes in elderly STEMI patients. The study found that Patients who received primary PCI exhibited a noteworthy reduction in the risk of two-year all-cause mortality, major adverse cardiac and cerebrovascular events (MACCE), and cardiac death compared to those who did not undergo reperfusion.
The observational study was published in the International Journal of Cardiology Cardiovascular Risk and Prevention.
Older Patients aged ≥75, face high mortality due to age-related comorbidities due to with ST-segment elevation myocardial infarction (STEMI). Hence, researchers using the China Acute Myocardial Infarction Registry aimed to assess primary PCI prevalence and outcomes in these older patients. Despite guidelines supporting invasive management, the real-world scenario shows declining primary PCI rates with age, raising concerns about disparities between developed and developing countries like China. The research addresses the gap by examining whether primary PCI improves outcomes in older Chinese STEMI patients, including those aged ≥85.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.